AI Insight
Two individuals known for their skepticism toward antidepressant medications, Laura Delano and David Cohen, have been appointed to the National Institute of Mental Health's advisory council. These pending appointments have prompted concern among researchers and clinicians that a key federal body influencing mental health research priorities and funding may be subject to political influence. Critics argue that placing antidepressant skeptics in advisory roles could undermine evidence-based policy and scientific consensus on psychiatric treatment.
Why it matters
The composition of NIH advisory councils directly shapes research funding priorities and public health guidance, meaning ideologically motivated appointments could have downstream effects on mental health policy, treatment access, and the direction of psychiatric science in the United States.
Pending appointments of Laura Delano and David Cohen raise concerns that key advisory groups are becoming politicized
Source: Two skeptics of antidepressant drugs named to NIH mental health council